[Effective danazol therapy for a patient with Evans syndrome]

Case report OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-02 ⓘ

Danazol therapy produced excellent and sustained improvement in platelet counts and hemoglobin for a 66-year-old man with refractory Evans syndrome, indicating its potential benefit for this condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol administered to a 66-year-old man with Evans syndrome, which was refractory to prednisolone therapy and pulse therapy with methylprednisolone. Danazol therapy produced an excellent and sustained improvement, increasing platelet counts and Hb concentrations. Recently, danazol therapy has been reported to be of benefit to severe idiopathic thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AIHA). And this case marked a favorable effect also on Evans syndrome, which has both characters as ITP and as AIHA. The aim of this paper is to suggest that the administration of danazol has a positive effect on Evans syndrome and probably on other various thrombocytopenic diseases and syndromes, especially on refractory cases.

My notes (saved in your browser only)

MeSH descriptors

Anemia, Hemolytic, Autoimmune Danazol Purpura, Thrombocytopenic, Idiopathic Aged Anemia, Hemolytic, Autoimmune Anemia, Hemolytic, Autoimmune Danazol Hemoglobins Hemoglobins Humans Male Platelet Count Purpura, Thrombocytopenic, Idiopathic Purpura, Thrombocytopenic, Idiopathic Syndrome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T04:34:38.715789+00:00
pubmed
last seen: 2026-10-08T21:59:37.277143+00:00
License: CC0 · commercial use OK